Essay
Evidence based medicine was named in the late twentieth century, but it was born from a much longer argument about how physicians should know whether a treatment works. Its history runs through bedside observation, numerical comparison, hospital records, controlled trials, medical statistics, and the effort to make clinical authority answerable to explicit evidence.
Its historical significance lies in the shift from medicine grounded mainly in expert training and customary judgment toward medicine that asked clinicians to combine experience with critically appraised research, patient circumstances, and transparent standards of proof.
Historical Setting
The phrase "evidence based medicine" is recent, but the problem it named is old. Physicians had long relied on a mixture of learned authority, personal experience, patient testimony, anatomical theory, and memorable cases. The difficulty was not that earlier medicine lacked observation. It was that observation could be selective, records could be uneven, and improvement after treatment did not prove that treatment had caused recovery.
This problem was especially visible in therapies that seemed plausible but produced uncertain results. Bleeding, purging, proprietary remedies, diet, rest, and surgery could all be defended from experience because some patients improved after receiving them. Yet patients also recovered naturally, declined despite treatment, or differed in ways that made comparison difficult.
The birth of evidence based medicine therefore belongs to a wider history of controlled comparison. It is closely connected to the history of clinical trials, the history of medical statistics, and the growth of medical records as tools for comparing groups rather than merely preserving individual case stories.
Early Comparisons
Long before randomization and systematic review, some practitioners tried to discipline experience by arranging comparisons. These early efforts were limited, but they showed why medical judgment needed more than memory and professional confidence.
In 1747, naval surgeon James Lind compared several treatments for scurvy among sailors aboard HMS Salisbury. His experiment was small and did not follow modern trial rules, but it became a landmark because it set treatments beside one another under broadly similar conditions and made therapeutic comparison part of the story of medical reform.
In the early nineteenth century, Pierre Charles Alexandre Louis and others associated with the Paris clinical school used what they called the numerical method to compare outcomes in groups of patients. Louis's work on bloodletting did not end therapeutic controversy, but it challenged the authority of dramatic individual cases by asking whether counted results supported customary treatment.
Nineteenth-century public-health investigation also mattered. The work of John Snow on cholera showed that careful mapping, comparison, and inference could overturn accepted explanations even before all mechanisms were fully settled. That tradition connected clinical evidence to the broader history of epidemiology.
Trial Culture
The twentieth century gave therapeutic comparison new institutional force. Statistical methods, state-supported research, wartime and postwar public health, and stronger drug regulation all encouraged more formal testing. The crucial change was not simply that doctors observed more carefully. It was that investigators increasingly designed studies to reduce bias before treatment began.
Random allocation became central because it helped prevent investigators from placing sicker or healthier patients into one treatment group. The Medical Research Council's streptomycin trial for pulmonary tuberculosis, reported in 1948, became a famous example of this new culture of planned comparison. It did not invent every element of modern trial design, but it helped make randomization, defined eligibility, follow-up, and statistical interpretation models for later clinical research.
This mattered for medicine because it altered the moral and practical status of uncertainty. If physicians genuinely did not know which treatment was better, then a carefully organized trial could be presented as a responsible way to learn rather than as a departure from care. That claim would later become central to research ethics, trial regulation, and the acceptance of controlled studies in ordinary medical practice.
Cochrane and Review
Evidence based medicine also grew from dissatisfaction with how medical systems used research once studies had been completed. The problem was not only producing trials. It was finding, judging, summarizing, and applying them without letting habit or prestige decide the answer.
British epidemiologist Archie Cochrane argued that health services should pay closer attention to evidence about effectiveness. His 1972 book Effectiveness and Efficiency became influential because it tied clinical uncertainty to public responsibility: if resources were limited, medicine needed better ways to know which interventions actually helped.
A single trial could be misleading or too small. Systematic review methods developed to gather studies according to explicit criteria, assess their quality, and synthesize results. Work in perinatal medicine, especially associated with Iain Chalmers and collaborators, helped show how organized reviewing could reveal patterns that scattered reports left unclear.
Founded in 1993, the Cochrane Collaboration embodied the belief that medical decisions should be supported by maintained, critical summaries of research. Its name linked the new review movement to Cochrane's demand that medicine become more accountable about effectiveness.
McMaster Movement
The modern phrase "evidence based medicine" is most closely associated with McMaster University in Canada and with clinicians including Gordon Guyatt, David Sackett, and their colleagues. In the early 1990s, they presented evidence based medicine as a new approach to clinical learning: ask answerable questions, search for the best available evidence, critically appraise it, and apply it to the care of individual patients.
This teaching program did not say that clinical experience was useless. Its claim was sharper and more unsettling: unsystematic experience and expert opinion should not sit at the top of medical authority simply because they were senior, customary, or confident. Research design, magnitude of effect, bias, and applicability had to be examined explicitly.
The movement fitted a broader late twentieth-century medical world shaped by expanding journals, computerized databases, cost pressure, medical specialization, patient advocacy, and concern about variation in care. It also depended on changes in medical education, because evidence based medicine had to be taught as a set of habits: framing questions, reading papers, interpreting statistics, and judging whether research findings applied to the person in front of the clinician.
Debate
The rise of evidence based medicine did not end argument about medical judgment. It reorganized that argument around hierarchies of evidence, guideline authority, patient individuality, and the place of professional experience.
Randomized trials are powerful for some questions, especially comparisons of interventions, but they cannot by themselves settle all problems of diagnosis, prognosis, causation, patient preference, or local feasibility. Critics warned that a narrow reading of evidence could make medicine appear more certain than it was.
Evidence based medicine worked with averages, probabilities, and measured outcomes, but clinical care still occurred one patient at a time. Its most careful defenders therefore emphasized integration: research evidence, clinical expertise, and the values and circumstances of the patient had to be considered together.
Evidence based guidelines promised to reduce ineffective variation and make recommendations more transparent. They also raised concerns about bureaucracy, cost control, industry influence, and the risk that complex judgment might be reduced to compliance with simplified rules.
Legacy
Evidence based medicine did not create modern medicine by itself. It inherited older traditions of observation, experiment, public health, hospital statistics, record keeping, and trial design. Its novelty was to gather those traditions into a clinical ethic: medical decisions should be open to question, supported by the best available evidence, and clear about the strength and limits of that evidence.
Its legacy can be seen in journal clubs, clinical guidelines, systematic reviews, evidence hierarchies, critical appraisal teaching, and the expectation that claims about treatment should be traceable to methods rather than reputation alone. That expectation changed the tone of medical authority. A recommendation now had to answer not only "Who says so?" but "What kind of evidence supports it, and how well does that evidence fit this case?"
Further Reading
A foundational critique of medical practice and health services from the perspective of effectiveness, uncertainty, and responsible use of evidence.
Central statements of the late twentieth-century teaching program that joined clinical expertise to critical appraisal of research evidence.
A major historical study of therapeutic reform, clinical trials, and the changing standards used to judge medical interventions.
Useful for understanding how numerical thresholds, risk categories, and population evidence reshaped twentieth-century prescribing and medical decision-making.